Common genetic variation and survival after colorectal cancer diagnosis: A genome-wide analysis

Carcinogenesis

Volumn 37, Issue 1, 2016, Pages 87-95

  Phipps, Amanda I ^a,b   Passarelli, Michael N ^a,b   Chan, Andrew T ^c,d   Harrison, Tabitha A ^b   Jeon, Jihyoun ^b   Hutter, Carolyn M ^b   Berndt, Sonja I ^e   Brenner, Hermann ^f   Caan, Bette J ^g   Campbell, Peter T ^h   Chang Claude, Jenny ^f   Chanock, Stephen J ^e   Cheadle, Jeremy P ⁱ   Curtis, Keith R ^b   Duggan, David ^j   Fisher, David ^k   Fuchs, Charles S ^d,l   Gala, Manish ^m   Giovannucci, Edward L ^d,m   Hayes, Richard B ⁿ   Hoffmeister, Michael ^f   Hsu, Li ^a,b   Jacobs, Eric J ^f   Jansen, Lina ^f   Kaplan, Richard ^k   Kap, Elisabeth J ^f   Maughan, Timothy S ^o   Potter, John D ^a,b,p   Schoen, Robert E ^q   Seminara, Daniela ^e   Slattery, Martha L ^r   West, Hannah ⁱ   White, Emily ^a,b   Peters, Ulrike ^a,b   Newcomb, Polly A ^a,b   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g DIVISION OF RESEARCH   (United States)

^h AMERICAN CANCER SOCIETY   (United States)

ⁱ CARDIFF UNIVERSITY   (United Kingdom)

^j TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l DANA FARBER CANCER INSTITUTE   (United States)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p MASSEY UNIVERSITY   (New Zealand)

^q UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^r UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; COHORT ANALYSIS; COLORECTAL NEOPLASMS; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84954357203     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv161     Document Type: Article

References (50)

1. Phipps, A.I. et al. (2012) Temporal trends in incidence and mortality rates for colorectal cancer by tumor location: 1975-2007. Am. J. Public Health, 102, 1791-1797.
2. O'Connell, J.B. et al. (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl. Cancer Inst., 96, 1420-1425.
3. Peters, U. et al. (2013) Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology, 144, 799-807.
4. Peters, U. et al. (2012) Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum. Genet., 131, 217-234.
5. Tenesa, A. et al. (2010) Ten common genetic variants associated with colorectal cancer risk are not associated with survival after diagnosis. Clin. Cancer Res., 16, 3754-3759.
6. Houlston, R.S. et al. (2008) Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat. Genet., 40, 1426-1435.
7. Houlston, R.S. et al. (2010) Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet., 42, 973-977.
8. Tomlinson, I.P. et al. (2008) A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat. Genet., 40, 623-630.
9. Tomlinson, I.P. et al. (2011) Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet., 7, e1002105.
10. Kocarnik, J.D. et al. (2010) Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and metaanalysis. Cancer Epidemiol. Biomarkers Prev., 19, 3131-3139.
11. Hutter, C.M. et al. (2010) Characterization of the association between 8q24 and colon cancer: gene-environment exploration and meta-analysis. BMC Cancer, 10, 670.
12. Jia, W.H. et al. (2013) Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer. Nat. Genet., 45, 191-196.
13. Afzal, S. et al. (2011) The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer. Pharmacogenomics, 12, 1257-1267.
14. Curtin, K. et al. (2007) Thymidylate synthase polymorphisms and colon cancer: associations with tumor stage, tumor characteristics and survival. Int. J. Cancer, 120, 2226-2232.
15. Phipps, A.I. et al. (2012) Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. Gastroenterology, 143, 51-4.e4.
16. Xing, J. et al. (2011) GWAS-identified colorectal cancer susceptibility locus associates with disease prognosis. Eur. J. Cancer, 47, 1699-1707.
17. Cicek, M.S. et al. (2009) Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol. Biomarkers Prev., 18, 2492-2500.
18. Passarelli, M.N. et al. (2011) Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women. Genes. Chromosomes Cancer, 50, 875-886.
19. Rimm, E.B. et al. (1991) Prospective study of alcohol consumption and risk of coronary disease in men. Lancet, 338, 464-468.
20. Belanger, C.F. et al. (1978) The nurses' health study. Am. J. Nurs., 78, 1039-1040.
21. Belanger, C. et al. (1980) The nurses' health study: current findings. Am. J. Nurs., 80, 1333.
22. Colditz, G.A. et al. (1997) The Nurses' Health Study: 20-year contribution to the understanding of health among women. J. Womens. Health, 6, 49-62.
23. Steering Committee of the Physicians' Health Study Research Group. (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med., 321, 129-135.
24. Prorok, P.C. et al. (2000) Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin. Trials, 21, 273S-309S.
25. Gohagan, J.K. et al. (2000) The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin. Trials, 21, 251S-272S.
26. White, E. et al. (2004) VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am. J. Epidemiol., 159, 83-93.
27. The Women's Health Initiative Study Group. (1998) Design of the Women's Health Initiative clinical trial and observational study. Control Clin. Trials, 19, 61-109.
28. Calle, E.E. et al. (2002) The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer, 94, 2490-2501.
29. Slattery, M.L. et al. (1997) Energy balance and colon cancer-beyond physical activity. Cancer Res., 57, 75-80.
30. Brenner, H. et al. (2011) Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann. Intern. Med., 154, 22-30.
31. Lilla, C. et al. (2006) Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol. Biomarkers Prev., 15, 99-107.
32. Maughan, T.S. et al. (2011) Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet, 377, 2103-14.
33. Wasan, H. et al. (2014) Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial. Lancet Oncol., 15, 631-9.
34. Chan, A.T. et al. (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA, 302, 649-658.
35. Curb, J.D. et al. (2003) Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann. Epidemiol., 13, S122-S128.
36. Miller, A.B. et al. (2000) Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin. Trials, 21, 400S-406S.
37. Li, Y. et al. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.
38. Devlin, B. et al. (1999) Genomic control for association studies. Biometrics, 55, 997-1004.
39. Moon, Y.A. et al. (2009) Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice. J. Lipid Res., 50, 412-423.
40. Lin, X.F. et al. (2014) Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study. Mol. Biol. Rep., 41, 2989-2997.
41. Augustin, G. et al. (2013) Lower incidence of hepatic metastases of colorectal cancer in patients with chronic liver diseases: meta-analysis. Hepatogastroenterology, 60, 1164-1168.
42. Lee, Y.I. et al. (2012) Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study. J. Gastroenterol. Hepatol., 27, 91-95.
43. Min, Y.W. et al. (2012) Influence of non-alcoholic fatty liver disease on the prognosis in patients with colorectal cancer. Clin. Res. Hepatol. Gastroenterol., 36, 78-83.
44. Togawa, K. et al. (2000) Intestinal cell kinase (ICK) localizes to the crypt region and requires a dual phosphorylation site found in map kinases. J. Cell. Physiol., 183, 129-139.
45. Fu, Z. et al. (2009) Intestinal cell kinase, a MAP kinase-related kinase, regulates proliferation and G1 cell cycle progression of intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol., 297, G632-G640.
46. McIlwain, C.C. et al. (2006) Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene, 25, 1639-1648.
47. Grady, W.M. (2007) Making the case for DCC and UNC5C as tumor-suppressor genes in the colon. Gastroenterology, 133, 2045-2049.
48. Aschele, C. et al. (2004) Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracilbased chemotherapy. J. Clin. Oncol., 22, 3758-3765.
49. Shibata, D. et al. (1996) The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med., 335, 1727-1732.
50. Jamieson, R.V. et al. (2007) Characterization of a familial t(16;22) balanced translocation associated with congenital cataract leads to identification of a novel gene, TMEM114, expressed in the lens and disrupted by the translocation. Hum. Mutat., 28, 968-977.Supplementary material